Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis

Purpose: Trefoil factor family (TFF) peptides are thought to contribute to epithelial protection and restitution by virtue of their protease-resistant nature and their strong affinity for mucins. However, they are often overexpressed in tumors, where they seem to be negative prognostic factors, possibly contributing to tumor spread, although the precise mechanisms have not been defined. Experimental Design: Tissue sections from 111 patients with curatively resected advanced gastric carcinoma were immunohistochemically stained for TFF2, ITF (TFF3), and CD34. Microvessel density was expressed as number and area of microvessels. Results were correlated with clinicopathological characteristics and patient survival. Results: Forty-nine (44.1%) and 41 (36.9%) tumors were immunohistochemically positive for TFF3 and TFF2, respectively. Among the various clinicopathologic variables, overexpression of TFF3 had a significant correlation with patient age only. In addition, a significantly higher prevalence of positive TFF2 staining was detected in large, diffuse tumors and in tumors with lymph node metastasis. The number of microvessels had a significant correlation with both TFF3 and TFF2 staining, whereas the area of microvessels had a significant correlation only with TFF3 staining. Both TFF3 and TFF2 were independent predictors of a worse disease-free survival. TFF3 had a gender-specific negative survival advantage, with a 91.3% disease-free survival in female patients with TFF3-negative advanced gastric carcinoma. Conclusions: Induction of increased tumor vascularity might be one of the mechanisms by which TFFs confer metastatic phenotype and frequent disease recurrence in gastric carcinomas. Female patients with TFF3-negative advanced gastric carcinoma have comparable survival as that reported for patients with early gastric carcinoma.

[1]  Z. Hall.  Cancer , 1906, The Hospital.

[2]  H. Ohkura,et al.  [Chemoendocrine therapy of gastric "scirrhous" carcinoma]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[3]  R. Poulsom,et al.  Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach , 1995, The Journal of pathology.

[4]  R. Playford,et al.  Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. , 1995, Clinical science.

[5]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[6]  L. Thim,et al.  Rolling in the clover: trefoil factor family (TFF)‐domain peptides, cell migration and cancer , 1997, FEBS letters.

[7]  F. May,et al.  Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells , 1997, The Journal of pathology.

[8]  E. Kobayashi,et al.  Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro. , 1999, Cancer letters.

[9]  D. Taupin,et al.  Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor , 2000, Molecular and Cellular Biology.

[10]  K. Alitalo,et al.  Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis , 2000, Oncogene.

[11]  D. Taupin,et al.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Y. Chen,et al.  Transcription factor NF-kappaB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells. , 2000, Biochemical and biophysical research communications.

[13]  M. Fini,et al.  Trefoil peptides promote restitution of wounded corneal epithelial cells. , 2001, Experimental cell research.

[14]  H. Aburatani,et al.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.

[15]  R. Hershberg,et al.  Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.

[16]  Masae Tatematsu,et al.  Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  B. Jenkins,et al.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.

[18]  J. Udagawa,et al.  Expression of Cytoplasmic TFF2 Is a Marker of Tumor Metastasis and Negative Prognostic Factor in Gastric Cancer , 2003, Laboratory Investigation.

[19]  M. Mareel,et al.  Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signaling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Ji-yeon Lee,et al.  Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. , 2003, Genomics.

[21]  Hong-gang Yu,et al.  The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rat , 2003, Regulatory Peptides.

[22]  G. Kouraklis,et al.  Brief tamoxifen pretreatment enhances the chemosensitivity of gastric carcinoma cells to 5-fluorouracil in vitro. , 2003, Anticancer research.

[23]  J. Lee,et al.  Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. , 2004, Gastroenterology.

[24]  K. Devaney,et al.  Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. , 2004, Gastroenterology.

[25]  S. Horvath,et al.  Trefoil factor 3 is overexpressed in human prostate cancer , 2004, The Prostate.

[26]  James R. Goldenring,et al.  Gastric Cancer Originating from Bone Marrow-Derived Cells , 2004, Science.

[27]  J. Udagawa,et al.  Expression of regenerating gene I in gastric adenocarcinomas , 2004, Cancer.

[28]  Eithne Costello,et al.  Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis , 2004, International journal of cancer.